 |
The Journal of Neuroscience, August 6, 2003, 23(18):7069-7074
Previous Article | Next Article 
BRIEF COMMUNICATION
Selective Antagonism of GluR5 Kainate-Receptor-Mediated Synaptic Currents by Topiramate in Rat Basolateral Amygdala Neurons
Divina S. Gryder and
Michael A. Rogawski
Epilepsy Research Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-4457
Topiramate is a widely used antiepileptic agent whose mechanism of action is poorly understood. The drug has been reported to interact with various ion channel types, including AMPA/kainate receptors. In whole-cell voltage-clamp recordings from principal neurons of the rat basolateral amygdala, topiramate at low concentrations (IC50, 0.5 µM) selectively inhibited pharmacologically isolated excitatory synaptic currents mediated by kainate receptors containing the GluR5 subunit. Topiramate also partially depressed predominantly AMPA-receptor-mediated EPSCs, but with lower efficacy. Topiramate did not alter the degree of facilitation in paired-pulse experiments, and it reduced the amplitude of miniature EPSCs without affecting their frequency, demonstrating that the block of synaptic responses occurs postsynaptically. Inhibition of GluR5 kainate receptors could represent a key mechanism underlying the anticonvulsant activity of topiramate. Moreover, these results support the concept that GluR5 kainate receptors represent a novel target for antiepileptic drug development.
Key words: topiramate; kainate receptor; AMPA receptor; amygdala; synaptic current; patch-clamp recording
Received Mar. 4, 2003;
revised Jun. 9, 2003;
accepted Jun. 17, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
M. F. M. Braga, V. Aroniadou-Anderjaska, H. Li, and M. A. Rogawski
Topiramate Reduces Excitability in the Basolateral Amygdala by Selectively Inhibiting GluK1 (GluR5) Kainate Receptors on Interneurons and Positively Modulating GABAA Receptors on Principal Neurons
J. Pharmacol. Exp. Ther.,
August 1, 2009;
330(2):
558 - 566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Rogawski
Common Pathophysiologic Mechanisms in Migraine and Epilepsy
Arch Neurol,
June 1, 2008;
65(6):
709 - 714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Ireland, F. C. Lenal, A. R. Lorier, D. E. Loomes, T. Adachi, T. S. Alvares, J. J. Greer, and G. D. Funk
Distinct receptors underlie glutamatergic signalling in inspiratory rhythm-generating networks and motor output pathways in neonatal rat
J. Physiol.,
May 1, 2008;
586(9):
2357 - 2370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schubert, C. Drephal, and D. Albrecht
Gender-dependent ATPA-induced changes in long-term potentiation in the rat lateral amygdala
FASEB J,
April 1, 2008;
22(4):
1268 - 1274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Remy and H. Beck
Molecular and cellular mechanisms of pharmacoresistance in epilepsy
Brain,
January 1, 2006;
129(1):
18 - 35.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. L. Follett, W. Deng, W. Dai, D. M. Talos, L. J. Massillon, P. A. Rosenberg, J. J. Volpe, and F. E. Jensen
Glutamate Receptor-Mediated Oligodendrocyte Toxicity in Periventricular Leukomalacia: A Protective Role for Topiramate
J. Neurosci.,
May 5, 2004;
24(18):
4412 - 4420.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|